No Data
Goldman Sachs Maintains Geron(GERN.US) With Buy Rating
Goldman Sachs analyst Corinne Johnson maintains $Geron(GERN.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 53.6% and a total average return of 6.2% over the
Goldman Sachs Reaffirms Their Buy Rating on Geron (GERN)
Geron Corporation (NASDAQ:GERN): Hedge Funds Are Bullish On This US Stock to Buy Under $5 Now
Express News | Geron Corporation Announces Appointment of Jim Ziegler as Chief Commercial Officer
Biologics by McKesson's RYTELOTM, FDA Gets Approval For Treatment Of Patients With Low- To Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia
Leerink Partners Initiates Geron(GERN.US) With Buy Rating, Announces Target Price $7
Leerink Partners analyst Faisal Khurshid initiates coverage on $Geron(GERN.US)$ with a buy rating, and sets the target price at $7.According to TipRanks data, the analyst has a success rate of 90.0%